Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjalling Bosse

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 19, 2026
No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinomaFamke C Wakkerman, Cathalijne C B Post, Gitte Ørtoft, et al.
Journal of the National Cancer Institute|March 12, 2021
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort StudyMarthe M de Jonge, Cornelis D de Kroon, Denise J Jenner, et al.
Journal of the National Cancer Institute|March 11, 2021
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial CancerCathalijne C B Post, Ellen Stelloo, Vincent T H B M Smit, et al.
The Lancet. Digital Health|December 10, 2022
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohortsSarah Fremond, Sonali Andani, Jurriaan Barkey Wolf, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 29, 2019
Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar CancerKim E Kortekaas, Koen K Van de Vijver, Mariëtte I E van Poelgeest, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2019
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndromeEmma J Crosbie, Neil A J Ryan, Mark J Arends, et al.
Nature Medicine|July 1, 2024
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Nature Medicine|May 24, 2024
Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Obstetrical & Gynecological Survey|December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 TrialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Oncology|September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|June 19, 2026
No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinomaFamke C Wakkerman, Cathalijne C B Post, Gitte Ørtoft, et al.
Journal of the National Cancer Institute|March 12, 2021
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort StudyMarthe M de Jonge, Cornelis D de Kroon, Denise J Jenner, et al.
Journal of the National Cancer Institute|March 11, 2021
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial CancerCathalijne C B Post, Ellen Stelloo, Vincent T H B M Smit, et al.
The Lancet. Digital Health|December 10, 2022
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohortsSarah Fremond, Sonali Andani, Jurriaan Barkey Wolf, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 29, 2019
Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar CancerKim E Kortekaas, Koen K Van de Vijver, Mariëtte I E van Poelgeest, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2019
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndromeEmma J Crosbie, Neil A J Ryan, Mark J Arends, et al.
Nature Medicine|July 1, 2024
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Nature Medicine|May 24, 2024
Prediction of recurrence risk in endometrial cancer with multimodal deep learningSarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Obstetrical & Gynecological Survey|December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 TrialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Oncology|September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Pageof 17